Aji Bio-Pharma, DNDi to develop treatment for cutaneous leishmaniasis infections

Japan's Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development a...

October 1, 2020 | Thursday | News
Samsung Biologics, Panolos to develop solid tumor treatment

Samsung Biologics has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein in...

September 17, 2020 | Thursday | News
PharmAbcine signs oncology agreement with Binex

South Korea based PharmAbcine, a biotech company focusing on the development of antibody therapeutics, has announced&nbs...

September 3, 2020 | Thursday | News
Viva Biotech acquires major stake in Chinese CDMO

Viva Biotech (Shanghai) Co., Ltd. has entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to...

August 14, 2020 | Friday | News
Samsung Biologics expands drug product manufacturing facility in Incheon

South Korean firm Samsung Biologics has announced a plan to expand its Drug Product (DP) capability in line with increas...

July 24, 2020 | Friday | News
HOYA and Hitachi collaborate to supply Endoscopic Ultrasound Systems

HOYA Corporation and Hitachi, Ltd. on 6 July 2020 announced a five-year contract regarding Endoscopic Ultrasound Systems...

July 7, 2020 | Tuesday | News
PharmAbcine focuses on Ab therapeutics pipeline in oncology

South Korea based PharmAbcine, a biotech company focusing on the development of antibody therapeutics, announced that it...

July 3, 2020 | Friday | News
GSK partners with Samsung Biologics

UK headquartered GlaxoSmithKline plc and South Korea based Samsung Biologics have entered into a partnership to provide ...

May 25, 2020 | Monday | News
AstraZeneca receives $1B for Oxford’s COVID-19 vaccine

AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a ...

May 22, 2020 | Friday | News
Uni-Bio Science, Medlink to expand pharma e-commerce value chain

A fully integrated biopharmaceutical company Uni-Bio Science Group Limited announced on 15 May 2020 that its wholly...

May 15, 2020 | Friday | News
HALIX Celebrates Grand Opening of its State-of-the-Art cGMP Facility

With an official inauguration ceremony, HALIX celebrated the opening of its brand-new 6,700 m² cGMP facil...

November 24, 2019 | Sunday | News
Thermo Fisher Scientific invests $6 M to expand Viral Vector Manufacturing Facility

Thermo Fisher Scientific, the world leader in serving science, on 22nd Nov 2019, unveiled the $6 million expansion ...

November 22, 2019 | Friday | News
Samsung BioLogics implements N-1 perfusion for commercial application

Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device ...

August 13, 2019 | Tuesday | News
AUM Biosciences expands pipeline with new global license agreement

AUM Biosciences (AUM), an award-winning company focused on the development of innovative and affordable oncology medicin...

July 19, 2019 | Friday | News
Wize Pharma enters into JV with Cannabics Pharmaceuticals

Wize Pharma, an Israel based clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, ...

July 1, 2019 | Monday | News
Concept Life Sciences Opens New Pharmaceutical Manufacturing Support Services

Concept Life Sciences, a knowledge-based provider of integrated discovery, development and analytical services, on 18 Ju...

June 28, 2019 | Friday | News
Cobra Biologics, Symbiosis complete £4.8M viral vector supply chain collaboration

Cobra Biologics, an international contract development and manufacturing organisation (CDMO) focused on viral vecto...

June 26, 2019 | Wednesday | News
EMA accepts First "China-Developed" Biosimilar - Henlius HLX02 MAA for Review

Henlius, a leading biotech company in China developing both biosimilar and innovative biologics, on 21 June 20...

June 24, 2019 | Monday | News